The Human Genome Project (HGP) has profoundly changed biology and is rapidly catalyzing a transformation of medicine. This 3-billion-dollar, 15-year program evolved considerably as genomics technologies improved. Also, the government has poured an additional $10.5 billion into mrna vaccine companies since the pandemic began to accelerate the delivery of their products. In the case of metabolomics research, it is expected that steady investment will be made because it is a new field of medicine that is an excellent tool for health promotion. Our company has been recognized for its world-class technology in metabolomic research and has been recognized by Emory University School of Medicine, Seoul National University, Korea University, Yonsei University, Keiyo University in Japan, Keiyo University Professor Takayashi, and other academia in the United States, the Institute for Basic Science in Korea, and the Korea Centers for Disease Control and Prevention. We are also taking the lead in industrialization of RND and RNBD, etc.